Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathy,Age-related”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00436553
What this trial is testing

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Novartis 321
Not applicableLooking for participantsNCT07582042
What this trial is testing

Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).

Who this might be right for
Geographic Atrophy From Age-related Macular Degeneration
University of Utah 50
Testing effectiveness (Phase 2)UnknownNCT00485394
What this trial is testing

The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)

Who this might be right for
Age-Related Macular Degeneration
Othera Pharmaceuticals 198
Not applicableStudy completedNCT00358345
What this trial is testing

PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 347
Not applicableStudy completedNCT03333954
What this trial is testing

Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration

Who this might be right for
Dry Age-related Macular Degeneration
Science Corporation 5
Not applicableStudy completedNCT04641234
What this trial is testing

A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD).

Who this might be right for
Neovascular Age-related Macular Degeneration
Bayer 330
Testing effectiveness (Phase 2)Ended earlyNCT01577381
What this trial is testing

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Maculopathy
Pfizer 10
Not applicableLooking for participantsNCT05465252
What this trial is testing

Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression

Who this might be right for
Age-Related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 24
Large-scale testing (Phase 3)Active Not RecruitingNCT06668064
What this trial is testing

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

Who this might be right for
Wet Age Related Macular DegenerationwAMD
EyePoint Pharmaceuticals, Inc. 400
Early research (Phase 1)Looking for participantsNCT03178149
What this trial is testing

The Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 42
Not applicableStudy completedNCT02569892
What this trial is testing

Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration

Who this might be right for
Macular DegenerationRetinal Drusen
Stanford University 19
Not applicableStudy completedNCT03919019
What this trial is testing

Morpho-functional Changes After Oral Supplementation of Antioxidants and Anti-inflammatory Treatment in Age-Related Macular Degeneration.

Who this might be right for
Dry AMD
Fondazione G.B. Bietti, IRCCS 30
Testing effectiveness (Phase 2)Study completedNCT04331730
What this trial is testing

Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Alkahest, Inc. 107
Not applicableStudy completedNCT07428798
What this trial is testing

Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyDry Age Related Macular Degeneration
Marmara University Pendik Training and Research Hospital 14
Not applicableUnknownNCT02988895
What this trial is testing

Episcleral Brachytherapy for the Treatment of Wet AMD

Who this might be right for
Macular Degeneration, Choroidal Neovascularization
Salutaris Medical Devices, Inc. 11
Testing effectiveness (Phase 2)UnknownNCT02755428
What this trial is testing

Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases

Who this might be right for
Dry Age-related Macular Degeneration
Chinese Academy of Sciences 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07129239
What this trial is testing

High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM)

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Clinique de Retine de l'est 180
Not applicableStudy completedNCT04132401
What this trial is testing

AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care

Who this might be right for
Diabetic RetinopathyGlaucomaAge-Related Macular Degeneration+2 more
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 902
Testing effectiveness (Phase 2)Study completedNCT02914639
What this trial is testing

Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
OcuTerra Therapeutics, Inc. 44
Not applicableStudy completedNCT01243645
What this trial is testing

MP-1 Biofeedback: Pattern Stimulus Versus Audio-feedback in AMD

Who this might be right for
Age Related Macular Degeneration
University of Roma La Sapienza
Next Page